bioAffinity Technologies, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| BIAF | ADVB | BDSX | 8YY.SI | ISPC | RHY.AX | |
|---|---|---|---|---|---|---|
| Market cap | 3.76M | 3.47M | 226.74M | 41.60M | 2.12M | 24.77M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -4.9 | — | -97.7 | — | -1.1 | — |
| Price/book | 0.4 | 0.3 | 24.8 | 24.0 | 0.7 | 7.0 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −90.20% | −75.17% | +144.77% | +13.64% | −97.07% | −25.00% |
| Today | −8.15% | −4.55% | +2.09% | −4.00% | +6.75% | +11.11% |
The closest companies by business and industry (Diagnostics & Research). Prices may be delayed up to 20 min.
Latest news
All BIAF news ›BioStack Raises $9.5M | Ayble Health Raises $16M Series A
Check out today’s featured companies who have recently raised a round of funding, and be sure to check out the full list of past healthcare IT fundings. BioStack Raises $9.5M to Turn Global Hospital Data into Multimodal Training Datasets…
bioAffinity Technologies, Inc. (NASDAQ:BIAF) Sees Significant Decline in Short Interest
Posted by Danessa Lincoln on Nov 2nd, 2026 Read Our Latest Report on BIAF bioAffinity Technologies, Inc is a biotechnology company focused on developing diagnostic and therapeutic products for cancer and other serious diseases. The…
SimonMed Launches Two New Lung Imaging Technologies
Through a partnership with 4DMedical, the new FDA-cleared technologies will expand access to functional and quantitative lung analysis at SimonMed locations nationwide, helping physicians better evaluate respiratory symptoms and lung…
bioAffinity Technologies Highlights Importance of Link Between Early Lung Cancer Detection and Curative Treatment During National Lung Cancer Awareness Month
Benefits of CyPath® Lung to be shared with North Carolina patient advocacy and healthcare community at November 5 “Battle of the Blues” Event The Company will join others committed to advancing lung cancer awareness, research, and patient…
BioAtla Announces Formal Process to Evaluate Strategic Options to Monetize Assets
SAN DIEGO, March 02, 2026 (GLOBE NEWSWIRE) -- BioAtla, Inc. (NASDAQ: BCAB or the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the…
bioAffinity Technologies to Present New Perspectives on CyPath® Lung’s Use for Cancer Risk Assessment at CHEST 2026
Chief Medical Officer Gordon Downie, MD, to host CHEST 2026 Learning Theater on clinical use of CyPath® Lung Presentation to address current challenges in pulmonary nodule management a
Biodesix to Present New Real-World Evidence Supporting Integration of Nodify Lung® Testing into Routine Lung Nodule Care at CHEST 2026
Clinical Education and Implementation at CHEST 2026 Title : Precision Meets Protocol: Implementing Biomarkers into a Structured Nodule Management Care PathwayLocation : Learning Theater #4Date: Monday, October 19 | 10:15–11:00 am…
bioAffinity Technologies expands Lung diagnostics pipeline into COPD and Asthma
bioAffinity Technologies CEO Maria Zennes joined Steve Darling from Proactive to discuss the company's noninvasive lung cancer detection technology, reported 200% year-over-year growth in the second quarter, insurance reimbursement and…
GRAFTA Nanotech Inc. announced that it has received CAD 1.844 million in funding
GRAFTA Nanotech Inc. announced it has issued 9,220,000 subscription receipts at a price of CAD 0.2 each for aggregate gross proceeds of CAD 1,844,000 on August 7, 2026. The company has received... GRAFTA Nanotech Inc. announced that it has…
‘No acceptable offers’ for Liberation Bioindustries as firm seeks to plug $25m funding gap
Liberation Bioindustries has received “no acceptable offers” following a strategic review to explore a sale or joint venture, and still needs a sizable sum to get its contract biomanufacturing facility in Indiana up and running, says key…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com27
- stocktitan.net8
- biospace.com5
- prnewswire.com4
- tradingview.com4
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 73 articles, not a forecast.